US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 6.670
  • -0.180-2.63%
Close May 13 16:00 ET
  • 6.670
  • 0.0000.00%
Post 16:10 ET
1.92BMarket Cap-17.55P/E (TTM)

Taysha Gene Therapies (TSHA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
17.28%9.77M
171.27%5.49M
0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
Operating revenue
--0
17.28%9.77M
171.27%5.49M
--0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
Cost of revenue
Gross profit
Operating expense
83.31%43.49M
26.66%120.27M
53.89%33.79M
48.91%34.02M
28.24%28.74M
-14.48%23.72M
9.36%94.95M
13.16%21.95M
12.11%22.85M
-13.06%22.41M
Selling and administrative expenses
18.62%9.68M
16.98%33.87M
33.25%8.83M
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
-General and administrative expense
18.62%9.68M
16.98%33.87M
33.25%8.83M
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
Research and development costs
117.21%33.81M
30.91%86.4M
62.82%24.95M
72.25%25.75M
33.62%20.14M
-24.65%15.57M
16.24%66M
20.84%15.33M
26.76%14.95M
-23.84%15.07M
Operating profit
-103.01%-43.49M
-27.56%-110.5M
-41.98%-28.3M
-61.56%-34.02M
-25.61%-26.75M
11.96%-21.42M
-21.36%-86.62M
-26.18%-19.93M
-34.71%-21.06M
8.92%-21.3M
Net non-operating interest income expense
97.17%2.58M
33.97%9.16M
70.32%2.86M
51.42%3.15M
30.36%1.84M
-21.45%1.31M
579.52%6.84M
38.91%1.68M
675.41%2.08M
216.11%1.41M
Non-operating interest income
95.02%2.59M
32.91%9.22M
68.82%2.87M
50.40%3.17M
29.10%1.86M
-21.68%1.33M
94.29%6.94M
-11.50%1.7M
89.99%2.11M
545.74%1.44M
Non-operating interest expense
-52.63%9K
-38.24%63K
-45.45%12K
-37.50%15K
-37.04%17K
-34.48%19K
-97.96%102K
-96.91%22K
-98.37%24K
-98.13%27K
Other net income (expense)
-6.08%-1.5M
19.52%-7.66M
-353.67%-2.41M
71.54%-1.86M
-89.16%-1.97M
-1.43%-1.42M
75.46%-9.52M
-100.85%-531K
93.52%-6.55M
-34,833.33%-1.04M
Gain on sale of security
----
-7,593.75%-1.2M
-986.75%-736K
-489.33%-292K
-240.00%-273K
130.27%102K
100.05%16K
-99.87%83K
100.07%75K
--195K
Special income (charges)
----
--0
--0
--0
----
----
-96.43%-4.84M
--0
-685.39%-4.84M
----
-Less:Impairment of capital assets
----
--0
--0
--0
----
----
354.27%4.84M
--0
685.39%4.84M
----
Other non- operating income (expenses)
1.05%-1.5M
-37.63%-6.46M
-172.48%-1.67M
11.94%-1.57M
-37.27%-1.7M
-43.38%-1.52M
-196.09%-4.69M
60.67%-614K
-9,289.47%-1.78M
-41,333.33%-1.24M
Income before tax
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Income tax
Net income
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Net income continuous Operations
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Minority interest income
Net income attributable to the parent company
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Basic earnings per share
-50.00%-0.12
5.56%-0.34
-14.29%-0.08
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
Diluted earnings per share
-50.00%-0.12
5.56%-0.34
-14.29%-0.08
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 017.28%9.77M171.27%5.49M078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M
Operating revenue --017.28%9.77M171.27%5.49M--078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M
Cost of revenue
Gross profit
Operating expense 83.31%43.49M26.66%120.27M53.89%33.79M48.91%34.02M28.24%28.74M-14.48%23.72M9.36%94.95M13.16%21.95M12.11%22.85M-13.06%22.41M
Selling and administrative expenses 18.62%9.68M16.98%33.87M33.25%8.83M4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M
-General and administrative expense 18.62%9.68M16.98%33.87M33.25%8.83M4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M
Research and development costs 117.21%33.81M30.91%86.4M62.82%24.95M72.25%25.75M33.62%20.14M-24.65%15.57M16.24%66M20.84%15.33M26.76%14.95M-23.84%15.07M
Operating profit -103.01%-43.49M-27.56%-110.5M-41.98%-28.3M-61.56%-34.02M-25.61%-26.75M11.96%-21.42M-21.36%-86.62M-26.18%-19.93M-34.71%-21.06M8.92%-21.3M
Net non-operating interest income expense 97.17%2.58M33.97%9.16M70.32%2.86M51.42%3.15M30.36%1.84M-21.45%1.31M579.52%6.84M38.91%1.68M675.41%2.08M216.11%1.41M
Non-operating interest income 95.02%2.59M32.91%9.22M68.82%2.87M50.40%3.17M29.10%1.86M-21.68%1.33M94.29%6.94M-11.50%1.7M89.99%2.11M545.74%1.44M
Non-operating interest expense -52.63%9K-38.24%63K-45.45%12K-37.50%15K-37.04%17K-34.48%19K-97.96%102K-96.91%22K-98.37%24K-98.13%27K
Other net income (expense) -6.08%-1.5M19.52%-7.66M-353.67%-2.41M71.54%-1.86M-89.16%-1.97M-1.43%-1.42M75.46%-9.52M-100.85%-531K93.52%-6.55M-34,833.33%-1.04M
Gain on sale of security -----7,593.75%-1.2M-986.75%-736K-489.33%-292K-240.00%-273K130.27%102K100.05%16K-99.87%83K100.07%75K--195K
Special income (charges) ------0--0--0---------96.43%-4.84M--0-685.39%-4.84M----
-Less:Impairment of capital assets ------0--0--0--------354.27%4.84M--0685.39%4.84M----
Other non- operating income (expenses) 1.05%-1.5M-37.63%-6.46M-172.48%-1.67M11.94%-1.57M-37.27%-1.7M-43.38%-1.52M-196.09%-4.69M60.67%-614K-9,289.47%-1.78M-41,333.33%-1.24M
Income before tax -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Income tax
Net income -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Net income continuous Operations -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Minority interest income
Net income attributable to the parent company -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Basic earnings per share -50.00%-0.125.56%-0.34-14.29%-0.0810.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.09
Diluted earnings per share -50.00%-0.125.56%-0.34-14.29%-0.0810.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More